Suppr超能文献

男性的体型与冠心病。关于体型评估方法的综述

Body habitus and coronary heart disease in men. A review with reference to methods of body habitus assessment.

作者信息

Williams S R, Jones E, Bell W, Davies B, Bourne M W

机构信息

University of Wales Institute, Cardiff, U.K.

出版信息

Eur Heart J. 1997 Mar;18(3):376-93. doi: 10.1093/oxfordjournals.eurheartj.a015258.

Abstract

Table 1 is a synopsis of the major findings from an extensive literature on the association between human body habitus and coronary heart disease. Whilst some studies have used quite sophisticated laboratory procedures to quantify body fat most have relied upon anthropometric measurements to determine some component of body habitus. Of these, body weight and height are the simplest measurements and are, therefore, well-suited to large-scale prospective studies. Height and weight are highly reproducible measurements, although in the short term, weight can have considerable physiological variation associated with gastric emptying and state of hydration. Less reliable measurements than height and weight are skinfolds and body circumferences, both of which have been used extensively in cross-sectional and prospective analyses. For skinfolds, both the inter and intra-observer variability is affected by the measurement technique, location of the skinfold site, the skinfold caliper used and skinfold compressibility. As measurement error has been shown to be a function of skinfold thickness, accurate and repeatable skinfold measurements are particularly difficult to make in the obese. In these subjects, it is not always possible to locate a specific anatomical bony landmark or to pull a parallel skinfold away from the underlying tissue. Furthermore, in the extremely obese it is sometimes possible for a skinfold to be thicker than the jaws of the currently available commercial calipers. Alternately, body circumferences are obtainable in all subjects and have greater reproducibility than skinfolds. They are, therefore, the preferred method in obese subjects. However, there is considerable work to be done to establish their association with body fatness. The evidence examined in this review suggests that body weight is a poor predictor of coronary heart disease. Some studies have reported no difference in the body weight of coronary heart disease patients compared to subjects free of the disease, others found the body weight of subjects with coronary heart disease to be slightly greater, and one found the body weight of cardiac patients to be less than controls. Height, however, is associated with coronary heart disease in prospective studies with long-term and shorter-term follow-up periods and case-control designs. Fetal, infant and childhood under-nutrition may link shorter adult height and susceptibility to cardiovascular disease. Many researchers have studied the relationship between overweight and coronary heart disease by using a surrogate measurement of body fatness such as relative weight or a weight-for-height index. In general, results produced by these studies suggest weight-for-height indices, particularly the often used body mass index, are not strong predictors of coronary heart disease. Indeed case-control designs have consistently failed to show a relationship between body mass index and coronary heart disease. Inconsistent results from prospective studies, however, are difficult to interpret. To further confuse the situation, the body mass index has been examined in relation to different coronary heart disease end-points and adjusted for different confounding variables. Explaining the inconsistent results on the basis of length of follow-up is also not straightforward. When follow-up periods exceed 20 years, and sample size is small, however, this closer association has not been found, even with a long follow-up period. Whilst some studies have found no association after 15, 13 and 12 years others have reported a relationship after 8.5, 10, 12, 10 and 7 years. The 22 year follow-up evidence from the Framingham Study shows the strongest 'independent' association between body mass index and coronary heart disease. (ABSTRACT TRUNCATED)

摘要

表1总结了大量关于人体体型与冠心病之间关联的文献的主要研究结果。虽然一些研究使用了相当复杂的实验室程序来量化体脂,但大多数研究依靠人体测量学指标来确定体型的某些组成部分。其中,体重和身高是最简单的测量指标,因此非常适合大规模前瞻性研究。身高和体重的测量具有很高的可重复性,不过短期内,体重会因胃排空和水合状态而出现相当大的生理波动。比身高和体重可靠性更低的测量指标是皮褶厚度和身体周长,这两者在横断面分析和前瞻性分析中都有广泛应用。对于皮褶厚度测量,观察者间和观察者内的变异性都受测量技术、皮褶部位、所用皮褶卡尺以及皮褶可压缩性的影响。由于测量误差已被证明是皮褶厚度的函数,在肥胖者中进行准确且可重复的皮褶测量尤其困难。在这些受试者中,有时无法找到特定的解剖学骨性标志,也无法从下方组织拉开平行的皮褶。此外,在极度肥胖者中,有时皮褶厚度会超过现有商用卡尺的量程。相比之下,身体周长在所有受试者中都可测量,且比皮褶厚度测量具有更高的可重复性。因此,身体周长测量是肥胖受试者的首选方法。然而,要确定其与体脂的关联仍有大量工作要做。本综述所审视的证据表明,体重并不能很好地预测冠心病。一些研究报告称,冠心病患者的体重与未患该病的受试者相比并无差异,另一些研究发现冠心病患者的体重略高,还有一项研究发现心脏病患者的体重低于对照组。然而,在长期和短期随访期以及病例对照设计的前瞻性研究中,身高与冠心病有关联。胎儿期、婴儿期和儿童期的营养不良可能会导致成年后身高较矮以及易患心血管疾病。许多研究人员通过使用诸如相对体重或身高体重指数等体脂替代测量指标来研究超重与冠心病之间的关系。总体而言,这些研究结果表明,身高体重指数,尤其是常用的体重指数,并不是冠心病的有力预测指标。实际上,病例对照设计一直未能显示体重指数与冠心病之间存在关联。然而,前瞻性研究结果不一致,难以解读。更复杂的是,体重指数是针对不同的冠心病终点进行研究,并针对不同的混杂变量进行了调整。基于随访时间长短来解释这些不一致的结果也并非易事。当随访期超过20年且样本量较小时,即便随访期很长,也未发现这种更紧密的关联。虽然有些研究在15年、13年和12年后未发现关联,但另一些研究在8.5年、10年、12年、10年和7年后报告了两者之间的关系。弗雷明汉姆研究22年的随访证据显示,体重指数与冠心病之间存在最强的“独立”关联。(摘要截选)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验